XML 48 R22.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Reporting
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Segment Reporting

13. Segment Reporting

Operating segments are defined as components of the entity for which separate financial information is made available and that is regularly evaluated by the chief operating decision maker (CODM) in making decisions regarding resource allocation and assessing performance. The Company's CODM is its chief executive officer and the Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company is focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer.

The CODM assesses the Company's performance by reviewing GAAP net loss and significant expenses by function along with the annual budget. The chief operating decision maker considers budget-to-actual variances on a quarterly basis when making decisions about the allocation of operating and capital resources.

The following table provides information about the Company's single operating segment which includes significant expenses by function along with significant non-cash expense items.

 

 

Year Ended
December 31,

 

 

2024

 

 

2023

 

Revenue:

 

 

 

 

 

Collaboration and license revenue

 

2,816

 

 

 

21,049

 

Operating expenses:

 

 

 

 

 

Research and development:

 

 

 

 

 

Personnel expenses

 

31,742

 

 

 

24,165

 

Laboratory supplies, research materials and studies

 

31,468

 

 

 

30,101

 

Clinical studies

 

19,245

 

 

 

10,214

 

Facility-related and other

 

16,669

 

 

 

16,298

 

Stock-based compensation

 

4,846

 

 

 

2,876

 

Depreciation expense

 

3,380

 

 

 

4,499

 

General and administrative:

 

 

 

 

 

Personnel expenses

 

10,900

 

 

 

9,065

 

Legal and professional fees

 

7,380

 

 

 

7,119

 

Facility-related and other

 

6,576

 

 

 

6,976

 

Stock-based compensation

 

4,703

 

 

 

2,332

 

Depreciation Expense

 

728

 

 

 

862

 

Loss from operations

 

(134,821

)

 

 

(93,458

)

Other (expense) income:

 

 

 

 

 

Interest and other income, net

 

12,065

 

 

 

7,999

 

Interest expense

 

(3,653

)

 

 

(3,759

)

Loss on extinguishment of debt

 

(1,090

)

 

 

-

 

Net Loss

 

(127,499

)

 

 

(89,218

)